Company Description
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.
The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
| Country | China |
| Founded | 1998 |
| IPO Date | Sep 5, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 10 |
| CEO | Jianfei Zhang |
Contact Details
Address: NET Building, Room 306 Beijing, 100101 China | |
| Phone | 86 10 8481 7665 |
| Website | ftzy.com.cn |
Stock Details
| Ticker Symbol | PTHL |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001970544 |
| ISIN Number | KYG713991027 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jianfei Zhang | Chief Executive Officer and Chairman of the Board |
| Zhixin Li | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 1, 2025 | 6-K | Report of foreign issuer |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |
| Jul 30, 2025 | SCHEDULE 13G/A | Filing |
| Jun 16, 2025 | SCHEDULE 13G | Filing |
| Jun 13, 2025 | SCHEDULE 13G | Filing |
| May 5, 2025 | SCHEDULE 13G | Filing |